Sık Rastlanan Karaciğer Metastazları ve Modelleri

Ergül Eyol

-

Yıl 2014, Cilt: 4 Sayı: 1, 44 - 52, 27.07.2014

Öz

The most common malignant toumors develop metastasis and are a central problem in tumor therapy The metastasis of the gastrointestinal tract is most frequently found in the liver. In the following you can see the list of various types of cancer that have spread to the liver. the frist two types of cancer. will be described in more detail. 1-Colorectal cancer 2-Pancreaticcarcinoma 3-Gastric cancer 4-Lung cancer 5-Breast cancer Each year worldwide an estimated one million new cases of colorectal cancer are diagnosed and more than half a million people died from the disease (Parkin et al. 2002). Surgical resection can offers potential tretment for colon cancer. The prognosis of patients with colon cancer dependent on the occurrence of metastases. Every year pancreatic cancer causes approximately 200.000 deaths and it is one of the most malignant types of tumors, with the poor prognosis Pancreatic carcinom has a mean survival times of 5 months. To develop new diagnostic technologies and new treatments for liver metastases the availability of a preclinical model is mandatory.

Anahtar Kelimeler

Kolon, Pankreas, Karaciğer, Metastaz, Rat

Kaynakça

Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA- Cancer J Clin 2005; 55: 74-108.
Gillen CD, Walmsley RS, Prior P, Andrews HA, Allan RN (1994) Ulcerative colitis and Crohn’s disease: a comparison of the colorectal cancer risk in extensive colitis. Gut 35, 1590–1592
Nordlinger B, Guiguet M, Vaillant JC, Balladur P, Boudjema K, Bachellier P, Jaeck D (1996) Surgical resection of colorectal carcinoma metastases of the liver; Cancer 77, 1254-62
Cady B, Jenkins RL, Steele GD Jr, Lewis WD, Stone MD, McDermott WV, Jessup JM, Bothe A, Lalor P, Lovett EJ, Lavin P, Linehan DC. (1998) Surgical margin in hepatic resection for colorectal metastases: a critical and improvable
determinant of outcome. Ann Surg; 227, 566-71
Rath FW und Schönfelder M (2002) Weichteilsarkome des Erwachsenen: Standards, Molekularbiologie, Perspektiven
Beiträge zur Onkologie 56, Karger Verlag Freiburg, Basel
Ewing J (1928) Neoplastic diseases. Saunders –Verlag, Philadelphia, S. 125 -129
Adam R, Lucidi V, Bismuth H. (2004) Hepatic colorectal metastases: methods of improving resectability.
Surg clin N Am 84, 659-671
Bengmark S, Hafström L, Olson A. (1969) The natural history of primary and secondary liver tumours: The prognosis for conventionally treated patients with liver metastases. Digestion 6, 321-329
Cady B, Monson DO, Swinton NW (1970) Survival of patients after colonic resection for carcinoma with simultaneous liver metastases. Surg Gynecol Obstet 131, 697-700
Nielsen J, und BalslevI, Jenson HE (1971) Carcinoma of the colon with liver metastases:operative indications and prognosis. Acta Chir Scand 137, 463-465
Bengmark S, Hafström L, Olson A. (1972) The natural history of primary and secondary liver tumours: The prognosis for conventionally treated patients with liver metastases. Digestion 6, 321-329
Pettavel J, und Morgenthaler F (1978) Protracted arterial chemotherapy of liver tumors: an experience of 107 cases over a 12- year period.Prog Clin Cancer 7, 217-233
Fortner J, Silva J, Cox E, Golbey R, Gallowitz H, MacLean B (1984) Multivariate Analysis of a personal series of 247 patients with liver metastases from colorectal cancer:Treatment by intrahepatic chemotherapy. Ann Surg 199, 317-331
Jaffe BM, Donegan WL, Watson F, Pratt JS (1996) Factors influencing survival in patients with untreated hepatic metastases.Surg Gynecol Obstet 127, 1-11
Harmon KE, Ryan JA, Biehl TR, Faye TL (1999) Benefits and safety of hepatic resection for colorectal metastases.
Am J Surg 177, 402-405
Kemeny N, Cohen A, Seiter K, Conti JA, Sigurdson ER, Tao Y, Niedwiecki D, Botet J, Budd A (1993)
Randomized trial of hepatic arterial floxuridine, mitomycin, and carmustine versus floxuridine alone in previously treated patients with liver metastases from colorectal cancer.J Clin Oncol 11, 330-5
Kemeny N, Daly J, reichman B, Geller N, Botet J, Oderman P (1987) Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial. Ann Intern Med 107, 459-65
Chang AE, Schneider PD, Sugarbaker PH, Simpson C, Culnane M, Steinberg SM (1987)A perspective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg 206, 685-93
Wagman LD, Kemeny MM, Leong L, Terz JJ, Hill LR, Beatty JD, Kokal WA, Riihimaki DU, (1990) A prospective, randomized evaluation of the treatment of colorectal cancer metastatic to the Liver. J Clin Oncol 8, 1885-93
Rougier P, Laplanche A, Huguier M, Hay JM, Olliver JM, Escat J, Salmon R, Julien M, Roullet Audy JC, Gallot S (1992)
Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial. J Clin Oncol 10, 1112-8
Warshaw AL und Castillo CF (1992) Pancreatic carcinoma. N Engl J Med 326, 455-465)
Lowenfels AB, Maisonneuve P, Cavallini G, Ammann RW, Lankisch PG, Andersen JR, Dimagno EP, Andrén-Sandberg A, Domellöf L (1993) Pancreatitis and the risk of pancreatic cancer. N Engl J Med 328, 1433-7
Lowenfels, AB und Maisonneuve P (2004) Epidemiology and prevention of pancreatic cancer. Jpn J Clin Oncol 34, 238-44
Lowenfels AB und Maisonneuve P (2005) Risk factors for pancreatic cancer. J Cell Biochem 95, 649-56
Doll R, Peto R, Wheatley K, Gray R, Sutherland I (1994) Mortality in relation to smoking. 40 years’ observation on male british doctors. Bmj ;309, 901–11
Howe GR, Jain M, Burch JD, Miller AB (1991) Cigarette smoking and cancer of the pancreas: evidence from a population based control-study in Toronto Canada. Int J Cancer 47, 323–8
Zamboni G., Capelli P., Pesci A., Beghelli S., Lüttges J., Klöppel G. (2000) Pancreatic Head Mass: What Can Be Done? Classification: the Pathological Point of View.Journal of the Pancreas 1, 77-84
Ghadirian P, Lynch HT, Krewski D (2003) Epidemiology of pancreatic cancer an overviewCancer. Detect prev. 27 (2), 87-93
Michaud DS (2004) Epidemiology of pancreatic cancer. Minerva Chir. Apr 59, 99-111
Gudjonsson B (1987) Cancer of the pancreas. 50 years of surgery. Cancer 60, 2284.
Lüttges J, Vogel I, Menke M, Henne-Bruns D, Kremer B, Klöppel G (1998) The retroperitoneal resection margin and vessel involvement are important factors determining survival after pancreaticoduodenectomy for ductal adenocarcinoma of the head of the pancreas. Virchows Arch Path 433, 237–42
Ahmedin Jemal, Rebecca Siegel, Elizabeth Ward, Taylor Murray, Jiaquan Xu and Michael J. Thun. (2007)
Cancer Statistics, 2007. Cancer J Clin 57, 43-66
Li D, Xie K, Wolff R, Abbruzzese JL (2004) Pancreatic cancer Lancet 363, 1049-57
Friess H, J. Dingb, J. Kleeffa, L. Fenkella, J.A. Rosinskib,A.Guweidhia, J. F. Reidhaar-Olsonb, M. Korcc, J. Hammerb and M.W. Büchlera (2003) Microarray-based identification of differentially expressed growth- and metastasis-associated
genes in pancreatic cancer. CMLS, Cell. Mol. Life Sci. 60, 1180–1199
Alanen KA and Joensuu H. (1993) Longterm survival after pancreatic adenocarcinomaoften a misdiagnosis? Br J Cancer 68 (5), 1004-5
Lin W. C., T. P. Pretlow, T. G. Pretlow 2nd, L. A. Culp (1990A) Bacterial lacZ gene as a highly sensitive marker to detect micrometastasis formation during tumor progression. Cancer Res. 50, 2808-2817
Lin W. C., T. P. Pretlow, T. G. Pretlow 2nd, L. A. Culp (1990B): Development of micrometastases: earliest events detected with bacterial lacZ gene-tagged tumor cells. J. Natl. Cancer Inst. 82, 1497-1503
Brunner N., E. W. Thompson, M. Spang-Thomsen, J. Rygaard, K. Dano, J. A. Zwiebel (1992) lacZ transduced human breast cancer xenografts as an in vivo model for the study of invasion and metastasis. Eur. J. Cancer. 28A, 1989-1995
Kobayashi, K., H. Nakanishi, A. Masuda, N. Tezuka, M. Mutai, M. Tatematsu (1997) Sequential observation of micrometastasis formation by bacterial lacZ gen-tagged Lewis lung carcinoma cells. Cancer Lett. 112, 191-198
Culp L. A., W. C. Lin, N. R. Kleinman, N. M. Campero, C. J. Miller, J. L. Holleran (1998A) Tumor progression, micrometastasis, and genetic instability tracked with histochemical marker genes. Prog. Histochem. Cytochem. 33, XI-XV, 329-348
Culp L. A., W. Lin, N. R. Kleinman, K. L. O’Connor, R. Lecher (1998B) Earliest steps in primary tumor formation and micrometastasis resolved with histochemical markers of gene-tagged tumor cells. J. Histochem. Cytochem. 46, 557-568
Kruger, A., V. Schirrmacher, R. Khokha (1998) The bacterial lacZ gene: an important tool for metastasis research and evaluation of new cancer therapies. Cancer Metastasis Rev. 17, 285-294
Maurer-Gebhard, M., M. Schmidt, M. Azemar, E. Stocklin, W. Wels, B. Groner (1999) A novel animal model for the evaluation of the efficacy of drugs directed against the ErbB2 receptoron metastasis formation. Hybridoma 18, 69-75
Zhang, L., S. Kharbanda, S. W. MCLeskey, F. G. Kern (1999): Overexpression of fibroblast growth factor 1 in MCF-7 breast cancer cells facilitates tumor cell dissemination but does not support the development of macrometastases in the lungs or lymph nodes. Cancer Res. 59, 5023-5029
Holleran, J. L., C. J. Miller, N. L. Edgehouse, T. P. Pretlow, L. A. Culp (2002) Differential experimental micrometastasis to lung, liver, and bone with lacZ-tagged CWR22R prostate carcinoma cells. Clin. Exp. Metastasis 19, 17-24
Yang M, Baranov E, Jiang P, Sun FX, Li XM, Li L, Hasegawa S, Bouvet M, Al Tuwaijri M, Chishima T, Shimada H, Moossa AR, Penman S, Hoffman RM (2000) Whole-body optical imaging of green fluorescent protein-expressing tumors and metastases. Proc.Natl. Acad. Sci. U S A. 97, 1206-11
Bouvet M, Wang J, Nardin SR, Nassirpour R, Yang M, Baranov E, Jiang P, Moossa AR, Hoffman RM. (2002)
Real-Time optical imaging of primary tumor growth and multiple metastatic events in a pancreatic cancer orthotopic model. Cancer Res. 62 (5), 1534-40
Vooijs M. J. Jonkers, S. Lyons, A. Berns (2002): Noninvasive imaging of spontaneous retinoblastoma pathway-dependent tumors in mice. Cancer Res 62, 1862-1867
Adams J. Y., M. Johnson, M. Sato, F. Berger, S. S. Gambhir, M. Carey, M. L. Iruela- Arispe, L. Wu. (2002) Visualization of advanced human prostate cancer lesions in living mice by a targeted gene transfer vector and optical imaging. Nat. Med. 8, 891-897
Khanna C., K. Hunter (2005) Modeling metastasis in vivo. Carcinogenesis 26, 513-523
Petrowsky, Henrik MD ; Gonen, Mithat PhD ; Jarnagin, William MD ; Lorenz, Matthias MD ; DeMatteo, Ronald MD ; Heinrich, Stefan MD ; Encke, Albrecht MD ; Blumgart, Leslie MD ; Fong, Yuman MD (2002) Second Liver Resections Are Safe and Effective Treatment for Recurrent Hepatic Metastases from Colorectal Cancer: A Bi-institutional Analysis.
Annals of Surgery 235, 863-871
Rees M, und John TG (2001) Current status of surgery in colorectal metastases to the liver, Hepatogastroenterology. Mar-Apr;48(38):341-4
Takayasu K, Y Shima, Y Muramatsu, N Moriyama, T Yamada, M Makuuchi, H Hasegawa, S Hirohashi (1987) Hepatocellular carcinoma: treatment with intraarterial iodized oil with and without chemotherapeutic agents Radiology, Vol 163, 345-351
Bruix J, Llovet JM, Castells A, Montana X, Bru C, Ayuso MC, Vilana R, Rodes J. (1998) Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution. Hepatology 27, 1578–83.
Andrew S. Kennedy M.D., F.A.C.R.O, Douglas Coldwell M.D, Charles Nutting D.O, Ravi Murthy M.D., F.A.C.P, Daniel E. Wertman, Jr M.D., Stephen P. Loehr M.D. Carroll Overton M.D, Steven Meranze M.D, Jerry Niedzwiecki M.D, and Scott Sailer M.D. (2006) Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases.
International Journal of Radiation Oncology*Biology*Physics 65 (2), 412-425
Kuvshinoff Y. Fong (2007) Surgical Therapy of Liver Metastases. Seminars in Oncology 34, 177-185
Lau W Y, Lai E C H (2007) Hepatic resection for colorectal liver metastases. Singapore Med J; 48, 635–639
Gudjonsson B (1987) Cancer of the pancreas. 50 years of surgery. Cancer 60, 2284.
Parker S. L., Tong T., Bolden S., Wingo P. A., (1997) Cancer statistics. CA Cancer J Clin 47, 5-27
Urrutia P., Di Magno E. P., (1997) Pancreatic cancer: cellular and molecular mechanism. Encyclopedia of cancer II, 1201-1211
Takahashi T., Ishikura H., Motohara T., Okushiba S., Dohke M., Katoh H. (1997) Perineural invasion by ductal adenocarcinoma of the pancreas. J Surg Oncol 65, 164-70
Marczell A., Glaser K., Karner J., Mischinger H. J., Schratter-Sehn A., Tatzer G. (1998) Pancreatic and periampullary cancer, ACO-Manual (Austrian Society of Surgical Oncology) zu finden unter: www.aco.at/manual/pankreas/stat.html
Klöppel G und Heitz PU (1984) Nesidioblastosis: a clinical entity with heterogeneous lesions of the pancreas. In:
Falkmer S, Hakanson R, Sundler F (eds) Evolution and tumour pathology of the neuroendocrine system. Elsevier, Amsterdam New York Oxford, pp 349–370
Gibbs RA, Weinstock GM, Metzker ML, Muzny DM, Sodergren EJ, Scherer S, Scott G, Steffen D, Worley KC, Burch PE, Okwuonu G, Hines S, Lewis L, DeRamo C, Delgado O, Dugan-Rocha S, Miner G, Morgan M, Hawes A, Gill R, Celera , Holt RA, Adams MD, Amanatides PG, Baden-Tillson H, Barnstead M, Chin S, Evans CA, Ferriera S, Fosler C, Glodek A, Gu Z, Jennings D, Kraft CL, Nguyen T, Pfannkoch CM, Sitter C, Sutton GG, Venter JC, Woodage T, Smith D, Lee HM, Gustafson E, Cahill P, Kana A, Doucette-Stamm L, Weinstock K, Fechtel K, Weiss RB, Dunn DM, Green ED, Blakesley RW, Bouffard GG, De Jong PJ, Osoegawa K, Zhu B, Marra M,Schein J, Bosdet I, Fjell C, Jones S, Krzywinski M, Mathewson C, Siddiqui A, Wye N, McPherson J, Zhao S, Fraser CM, Shetty J, Shatsman S, Geer K, Chen Y, Abramzon S, Nierman WC, Havlak PH, Chen R, Durbin KJ, Egan A, Ren Y, Song XZ, Li B, Liu Y, Qin X, Cawley S, Worley KC, Cooney AJ, D'Souza LM, Martin K, Wu JQ, Gonzalez-Garay ML, Jackson AR, Kalafus KJ, McLeod MP, Milosavljevic A, Virk D, Volkov A, Wheeler DA, Zhang Z, Bailey JA, Eichler EE, Tuzun E, Birney E, Mongin E, Ureta-Vidal A, Woodwark C, Zdobnov E, Bork P, Suyama M, Torrents D, Alexandersson M, Trask BJ, Young JM, Huang H, Wang H, Xing H, Daniels S, Gietzen D, Schmidt J, Stevens K, Vitt U, Wingrove J, Camara F, Mar Albà M, Abril JF, Guigo R, Smit A, Dubchak I, Rubin EM, Couronne O, Poliakov A, Hübner N, Ganten D, Goesele C, Hummel O, Kreitler T, Lee YA, Monti J, Schulz H, Zimdahl H, Himmelbauer H, Lehrach H, Jacob HJ, Bromberg S, Gullings-Handley J, Jensen- Seaman MI, Kwitek AE, Lazar J, Pasko D, Tonellato PJ, Twigger S, Ponting CP, Duarte JM, Rice S, Goodstadt L, Beatson SA, Emes RD, Winter EE, Webber C, Brandt P, Nyakatura G, Adetobi M, Chiaromonte F, Elnitski L, Eswara P, Hardison RC, Hou M, Kolbe D, Makova K, Miller W, Nekrutenko A, Riemer C, Schwartz S, Taylor J, Yang S, Zhang Y, Lindpaintner K, Andrews TD, Caccamo M, Clamp M,Clarke L, Curwen V, Durbin R, Eyras E, Searle SM, Cooper GM, Batzoglou S, Brudno M, Sidow A, Stone EA, Venter JC, Payseur BA, Bourque G, López-Otín C, Puente XS, Chakrabarti K, Chatterji S, Dewey C, Pachter L, Bray N, Yap VB, Caspi A, Tesler G, Pevzner PA, Haussler D, Roskin KM, Baertsch R, Clawson H, Furey TS, Hinrichs AS, Karolchik D, Kent WJ, Rosenbloom KR, Trumbower H, Weirauch M, Cooper DN, Stenson PD, Ma B, Brent M, Arumugam M, Shteynberg D, Copley RR, Taylor MS, Riethman H, Mudunuri U, Peterson J, Guyer M, Felsenfeld A, Old S, Mockrin S, Collins F; Rat Genome Sequencing Project Consortium. (2004) Genome sequence of the Brown Norway rat yields insights into mammalian evolution Nature 428, 493-521
Cooper C. R., C. H. Chay, J. D. Gendernalik, H. L. Lee, J. Bhatia, R. S. Taichman, L. K. MCCauley, E. T. Keller, K. J. Pienta (2003) Stromal factors involved in prostate carcinoma metastasis to bone.Cancer 97, 739-747
De Wever O, Mareel M (2003) Role of tissue stroma in cancer cellinvasion. J. Pathol. 200, 429-447
Schmidt-Hansen, B., J. Klingelhofer, B. Grum-Schwensen, A. Christensen, S. Andresen, C. Kruse, T. Hansen, N. Ambartsumian, E. Lukanidin, M. Grigorian (2004): Functional significance of metastasis-inducing S100A4 (Mts1) in tumor-stroma interplay. J. Biol. Chem. 279, 24498-24504
Sikder, H., D. L. Huso, H. Zhang, B. Wang, B. Ryu, S. T. Hwang, J. D. Powell, R. M. Alani (2003): Disruption of ld1 reveals major differences in angiogenesis between transplanted and autothonous tumours. Cancer Cell 4, 291-299
Alani R. M., C. F. Silverthorn, K. Orosz. (2004) Tumor angiogenesis in mice and men. Cancer Biol. Ther. 3, 498-500
Germer CT, Isbert C, Albrecht D, Roggan A, Pelz J, Ritz JP, Müller G, Buhr HJ (1999) Laser-induced thermotherapy combined with hepatic arterial embolization in the treatment of liver tumors in a rat tumor model Ann Surg.230, 55-62
Hagenaars M, S. Zwaveling, P.J.K. Kuppen, N.G. Ensink, A.M.M. Eggermont, M.E. Hokland, P.H. Basse, C.J.H. Van de Velde, G.J. Fleuren and U. Nannmark (1998) Characteristics of Tumor Infiltration by Adoptivly Transferred and Endogenous Natural-Killer Cells in a Syngeneic Rat Model: Implications for the Mechanism Behind anti-Tumor Responses. Int. J. Cancer: 78, 783–789
Hagenaars M, Ron Koelemij, N. Geeske Ensink, Jaap D. H. van Eendenburg, Ronald L. P. van Vlierberghe, Alexander M. M. Eggermont, Cornelis J. H. van deVelde, Gert Jan Fleuren, Peter J. K. Kuppen (2000)The development of novel mouse monoclonal antibodies against the CC531 rat colonadenocarcinoma. Clin Exp Metastasis 18, 281–289
Marquet, R.L., D.L.Westbroek, and J.Jeekel (1984) Interferon treatment of a transplantable rat colon adenocarcinoma: importance of tumor site. Int.J.Cancer 33, 689-692
Thomas C, Nijenhuis AM, Timens W, et al. (1993) Liver metastasis model of colon cancer in the rat: immunohistochemical characterization. Invasion Metastasis 13, 102–112
Li X, Mikkelsen IM, Mortensen B, Winberg JO, Huseby NE (2004) Butyrate reduces liver metastasis of rat colon carcinoma cells in vivo and resistance to oxidative stress in vitro. Clin Exp Metastasis 21, 331-338
Nestler G, Schulz HU, Schubert D, Kruger S, Lippert H, Pross M (2005) Impact of taurolidine on the growth of CC531 coloncarcinoma cells in vitro and in a laparoscopic animal model in rats. Surg Endosc 19, 280-284
Oosterling SJ, van der Bij GJ, Meijer GA, Tuk CW, van Garderen E, van Rooijen N, Meijer S, van d S, Jr, Beelen, RH, van Egmond M (2005) Macrophages direct tumour histology and clinical outcome in a colon cancer model. J Pathol 207, 147-155
van Duijnhoven FH, Aalbers RI, Rovers JP, Terpstra OT, Kuppen PJ (2003) Immunological aspects of photodynamic therapy of liver tumors in a rat model for colorectal cancer. Photochem Photobiol 78, 235-240
van Duijnhoven FH, Tollenaar RA, Terpstra OT, Kuppen PJ (2005) Locoregional therapies of liver metastases in a rat CC531 coloncarcinoma model results in increased resistance to tumour rechallenge. Clin Exp Metastasis 22, 247-253
Wittmer A, Khazaie K, Berger MR (1999) Quantitative detection of lac-Z-transfected CC531 colon carcinoma cells in an
orthotopic rat liver metastasis model. Clin Exp Metastasis 17, 369-376
Saenger J., Leible M, Seelig MH, Berger MR (2004) Chemoembolisation of rat liver metastases with irinotecan and quantification of tumor cell reduction. J Cancer Res Clin Oncol 130, 203-210
Seelig MH, Leible M, Sanger J, Berger MR (2004) Chemoembolization of rat liver metastasis with microspheres and gemcitabine followed by evaluation of tumor cell load by chemiluminescence. Oncol Rep 11, 1107-1113
Rodenbach M, Eyol E, Seelig MH, Berger MR (2005) Combination treatment of CC531-lac-Z rat liver metastases by chemoembolization with pemetrexed disodium and gemcitabine. J Cancer Res Clin Oncol 131, 289-299
Mook, O. R., J. Van Marle, H. Vreeling-Sindelarova, R. Jonges, W. M. Frederiks, C. J. Van Norden (2003): Visualisation of early events in tumor formation of eGFP-transfected rat colon cancer cells in liver. Hepatology 38, 295-304
Matzku, S., Komitowski, D., Mildenberger, M.& Zoller, M. (1983). Characterization of BSp73, a spontaneous rat tumor and ist in vivo selected variants showing different metastasizing capacities. Invasion Metastasis 3, 109-123
Knierim M., Paku, S., Paweletz, N. and Spieß, E. (1986) Ultrastructural studies on the Lung colonization by nonmetastatic ret tumor cells. Anticancer. Res 6, 669-682.
Paweletz N. Paku, S., Werling, H. O. and Spiess, E. (1986) Experimental approaches to problems of invasion and metastasis. Anticancer. Res 6, 119-128
Ackerman NB. (1974) The blood supply of experimental liver metastases. IV. Changes in vascularity with increasing tumor growth. Surgery 75, 589–596
Archer SG, Gray BN. (1989) Vascularization of small liver metastases. Br J Surg 76, 545–548
Blanchard RJ, Grotenhuis I, Lafave JW, Perry JF, Jr. (1965) Blood supply to hepatic V2 carcinoma implants as measured by radioactive microspheres. Proc Soc Exp Biol Med 118, 465–468
Breedis C, Young G. (1954) The blood supply of neoplasms in the liver. Am J Pathol 30, 969–977
Aliberti C., M. Tilli, G. Benea and G. Fiorentini (2006) Trans-arterial Chemoembolization (TACE) of Liver Metastases from Colorectal Cancer Using Irinotecan-Eluting Beads: Preliminary Results. Anticancer Research 2, 3793-3796
Varela María, María Isabel Real, Marta Burrel, Alejandro Forner, Margarita Sala, Mercé Brunet, Carmen Ayuso, Lluis Castells, Xavier Montañá, Josep M. Llovet and Jordi Bruix (2007) Chemoembolization of hepatocellular carcinoma with drug eluting beads: Efficacy and doxorubicin pharmacokinetics Journal of Hepatology 46, 474-481
Teder H, und Johansson CJ. (1993) The effect of different dosages of degradable starch microspheres (Spherex) on the distribution of doxorubicin regionally administered to the rat. Anticancer Res 13, 2161-4
Taguchi T. (1995) Liver tumor targeting of drugs: Spherex, a vascular occlusive agent Gan To Kagaku Ryoho 22, 969-76.

Sık Rastlanan Karaciğer Metastazları ve Modelleri

Yıl 2014, Cilt: 4 Sayı: 1, 44 - 52, 27.07.2014

Ergül Eyol

Öz

Kötü huylu tümörler çoğunlukla metastaz geliştirirler. Bu kötü huylu tümörlerin metastazları tümör tedavide hala temel bir problemdir. Sindirim sistemi kanserlerinde ise metastazlar sıklıkla karaciğere olur. Aşağıda karaciğere metastaz yapan farklı kanser tipleri sıralanmakta olup en sık metastaz yapan iki kanser türü detaylı olarak anlatılacaktır.

1-Kolorektal kanser 2-Pankreas kanser 3-Mide kanseri 4-Akciğer kanseri 5-Göğüs kanseri

Her yıl bir milyon insan kolorektal kansere yakalanmakta ve bu hastalık nedeni ile yarım milyon insan ölmektedir (Parkin ve ark.). Cerrahi müdahale ile tam bir iyileşme sağlanabilmektedir. Ancak kolon kanserli hastaların prognozu, kanserin metastaz yapıp yapmadığına bağlıdır.

Her yıl 200.000 ölüm pankreas kanseri nedeni ile gerçekleşmekte ve malign tümörler içinde prognozu en kötü olanıdır. Ortalama 5 ay gibi bir yaşama şansı vardır.

Karaciğer metastazının engellenebilmesinde yeni diagnostik teknolojiler ve yeni tedaviler geliştirebilmek için preklinik modellerin kullanılması kaçınılmazdır.

Anahtar Kelimeler

Kolon; Pankreas; Karaciğer; Metastaz; Rat

Kaynakça

Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA- Cancer J Clin 2005; 55: 74-108.
Gillen CD, Walmsley RS, Prior P, Andrews HA, Allan RN (1994) Ulcerative colitis and Crohn’s disease: a comparison of the colorectal cancer risk in extensive colitis. Gut 35, 1590–1592
Nordlinger B, Guiguet M, Vaillant JC, Balladur P, Boudjema K, Bachellier P, Jaeck D (1996) Surgical resection of colorectal carcinoma metastases of the liver; Cancer 77, 1254-62
Cady B, Jenkins RL, Steele GD Jr, Lewis WD, Stone MD, McDermott WV, Jessup JM, Bothe A, Lalor P, Lovett EJ, Lavin P, Linehan DC. (1998) Surgical margin in hepatic resection for colorectal metastases: a critical and improvable
determinant of outcome. Ann Surg; 227, 566-71
Rath FW und Schönfelder M (2002) Weichteilsarkome des Erwachsenen: Standards, Molekularbiologie, Perspektiven
Beiträge zur Onkologie 56, Karger Verlag Freiburg, Basel
Ewing J (1928) Neoplastic diseases. Saunders –Verlag, Philadelphia, S. 125 -129
Adam R, Lucidi V, Bismuth H. (2004) Hepatic colorectal metastases: methods of improving resectability.
Surg clin N Am 84, 659-671
Bengmark S, Hafström L, Olson A. (1969) The natural history of primary and secondary liver tumours: The prognosis for conventionally treated patients with liver metastases. Digestion 6, 321-329
Cady B, Monson DO, Swinton NW (1970) Survival of patients after colonic resection for carcinoma with simultaneous liver metastases. Surg Gynecol Obstet 131, 697-700
Nielsen J, und BalslevI, Jenson HE (1971) Carcinoma of the colon with liver metastases:operative indications and prognosis. Acta Chir Scand 137, 463-465
Bengmark S, Hafström L, Olson A. (1972) The natural history of primary and secondary liver tumours: The prognosis for conventionally treated patients with liver metastases. Digestion 6, 321-329
Pettavel J, und Morgenthaler F (1978) Protracted arterial chemotherapy of liver tumors: an experience of 107 cases over a 12- year period.Prog Clin Cancer 7, 217-233
Fortner J, Silva J, Cox E, Golbey R, Gallowitz H, MacLean B (1984) Multivariate Analysis of a personal series of 247 patients with liver metastases from colorectal cancer:Treatment by intrahepatic chemotherapy. Ann Surg 199, 317-331
Jaffe BM, Donegan WL, Watson F, Pratt JS (1996) Factors influencing survival in patients with untreated hepatic metastases.Surg Gynecol Obstet 127, 1-11
Harmon KE, Ryan JA, Biehl TR, Faye TL (1999) Benefits and safety of hepatic resection for colorectal metastases.
Am J Surg 177, 402-405
Kemeny N, Cohen A, Seiter K, Conti JA, Sigurdson ER, Tao Y, Niedwiecki D, Botet J, Budd A (1993)
Randomized trial of hepatic arterial floxuridine, mitomycin, and carmustine versus floxuridine alone in previously treated patients with liver metastases from colorectal cancer.J Clin Oncol 11, 330-5
Kemeny N, Daly J, reichman B, Geller N, Botet J, Oderman P (1987) Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial. Ann Intern Med 107, 459-65
Chang AE, Schneider PD, Sugarbaker PH, Simpson C, Culnane M, Steinberg SM (1987)A perspective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg 206, 685-93
Wagman LD, Kemeny MM, Leong L, Terz JJ, Hill LR, Beatty JD, Kokal WA, Riihimaki DU, (1990) A prospective, randomized evaluation of the treatment of colorectal cancer metastatic to the Liver. J Clin Oncol 8, 1885-93
Rougier P, Laplanche A, Huguier M, Hay JM, Olliver JM, Escat J, Salmon R, Julien M, Roullet Audy JC, Gallot S (1992)
Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial. J Clin Oncol 10, 1112-8
Warshaw AL und Castillo CF (1992) Pancreatic carcinoma. N Engl J Med 326, 455-465)
Lowenfels AB, Maisonneuve P, Cavallini G, Ammann RW, Lankisch PG, Andersen JR, Dimagno EP, Andrén-Sandberg A, Domellöf L (1993) Pancreatitis and the risk of pancreatic cancer. N Engl J Med 328, 1433-7
Lowenfels, AB und Maisonneuve P (2004) Epidemiology and prevention of pancreatic cancer. Jpn J Clin Oncol 34, 238-44
Lowenfels AB und Maisonneuve P (2005) Risk factors for pancreatic cancer. J Cell Biochem 95, 649-56
Doll R, Peto R, Wheatley K, Gray R, Sutherland I (1994) Mortality in relation to smoking. 40 years’ observation on male british doctors. Bmj ;309, 901–11
Howe GR, Jain M, Burch JD, Miller AB (1991) Cigarette smoking and cancer of the pancreas: evidence from a population based control-study in Toronto Canada. Int J Cancer 47, 323–8
Zamboni G., Capelli P., Pesci A., Beghelli S., Lüttges J., Klöppel G. (2000) Pancreatic Head Mass: What Can Be Done? Classification: the Pathological Point of View.Journal of the Pancreas 1, 77-84
Ghadirian P, Lynch HT, Krewski D (2003) Epidemiology of pancreatic cancer an overviewCancer. Detect prev. 27 (2), 87-93
Michaud DS (2004) Epidemiology of pancreatic cancer. Minerva Chir. Apr 59, 99-111
Gudjonsson B (1987) Cancer of the pancreas. 50 years of surgery. Cancer 60, 2284.
Lüttges J, Vogel I, Menke M, Henne-Bruns D, Kremer B, Klöppel G (1998) The retroperitoneal resection margin and vessel involvement are important factors determining survival after pancreaticoduodenectomy for ductal adenocarcinoma of the head of the pancreas. Virchows Arch Path 433, 237–42
Ahmedin Jemal, Rebecca Siegel, Elizabeth Ward, Taylor Murray, Jiaquan Xu and Michael J. Thun. (2007)
Cancer Statistics, 2007. Cancer J Clin 57, 43-66
Li D, Xie K, Wolff R, Abbruzzese JL (2004) Pancreatic cancer Lancet 363, 1049-57
Friess H, J. Dingb, J. Kleeffa, L. Fenkella, J.A. Rosinskib,A.Guweidhia, J. F. Reidhaar-Olsonb, M. Korcc, J. Hammerb and M.W. Büchlera (2003) Microarray-based identification of differentially expressed growth- and metastasis-associated
genes in pancreatic cancer. CMLS, Cell. Mol. Life Sci. 60, 1180–1199
Alanen KA and Joensuu H. (1993) Longterm survival after pancreatic adenocarcinomaoften a misdiagnosis? Br J Cancer 68 (5), 1004-5
Lin W. C., T. P. Pretlow, T. G. Pretlow 2nd, L. A. Culp (1990A) Bacterial lacZ gene as a highly sensitive marker to detect micrometastasis formation during tumor progression. Cancer Res. 50, 2808-2817
Lin W. C., T. P. Pretlow, T. G. Pretlow 2nd, L. A. Culp (1990B): Development of micrometastases: earliest events detected with bacterial lacZ gene-tagged tumor cells. J. Natl. Cancer Inst. 82, 1497-1503
Brunner N., E. W. Thompson, M. Spang-Thomsen, J. Rygaard, K. Dano, J. A. Zwiebel (1992) lacZ transduced human breast cancer xenografts as an in vivo model for the study of invasion and metastasis. Eur. J. Cancer. 28A, 1989-1995
Kobayashi, K., H. Nakanishi, A. Masuda, N. Tezuka, M. Mutai, M. Tatematsu (1997) Sequential observation of micrometastasis formation by bacterial lacZ gen-tagged Lewis lung carcinoma cells. Cancer Lett. 112, 191-198
Culp L. A., W. C. Lin, N. R. Kleinman, N. M. Campero, C. J. Miller, J. L. Holleran (1998A) Tumor progression, micrometastasis, and genetic instability tracked with histochemical marker genes. Prog. Histochem. Cytochem. 33, XI-XV, 329-348
Culp L. A., W. Lin, N. R. Kleinman, K. L. O’Connor, R. Lecher (1998B) Earliest steps in primary tumor formation and micrometastasis resolved with histochemical markers of gene-tagged tumor cells. J. Histochem. Cytochem. 46, 557-568
Kruger, A., V. Schirrmacher, R. Khokha (1998) The bacterial lacZ gene: an important tool for metastasis research and evaluation of new cancer therapies. Cancer Metastasis Rev. 17, 285-294
Maurer-Gebhard, M., M. Schmidt, M. Azemar, E. Stocklin, W. Wels, B. Groner (1999) A novel animal model for the evaluation of the efficacy of drugs directed against the ErbB2 receptoron metastasis formation. Hybridoma 18, 69-75
Zhang, L., S. Kharbanda, S. W. MCLeskey, F. G. Kern (1999): Overexpression of fibroblast growth factor 1 in MCF-7 breast cancer cells facilitates tumor cell dissemination but does not support the development of macrometastases in the lungs or lymph nodes. Cancer Res. 59, 5023-5029
Holleran, J. L., C. J. Miller, N. L. Edgehouse, T. P. Pretlow, L. A. Culp (2002) Differential experimental micrometastasis to lung, liver, and bone with lacZ-tagged CWR22R prostate carcinoma cells. Clin. Exp. Metastasis 19, 17-24
Yang M, Baranov E, Jiang P, Sun FX, Li XM, Li L, Hasegawa S, Bouvet M, Al Tuwaijri M, Chishima T, Shimada H, Moossa AR, Penman S, Hoffman RM (2000) Whole-body optical imaging of green fluorescent protein-expressing tumors and metastases. Proc.Natl. Acad. Sci. U S A. 97, 1206-11
Bouvet M, Wang J, Nardin SR, Nassirpour R, Yang M, Baranov E, Jiang P, Moossa AR, Hoffman RM. (2002)
Real-Time optical imaging of primary tumor growth and multiple metastatic events in a pancreatic cancer orthotopic model. Cancer Res. 62 (5), 1534-40
Vooijs M. J. Jonkers, S. Lyons, A. Berns (2002): Noninvasive imaging of spontaneous retinoblastoma pathway-dependent tumors in mice. Cancer Res 62, 1862-1867
Adams J. Y., M. Johnson, M. Sato, F. Berger, S. S. Gambhir, M. Carey, M. L. Iruela- Arispe, L. Wu. (2002) Visualization of advanced human prostate cancer lesions in living mice by a targeted gene transfer vector and optical imaging. Nat. Med. 8, 891-897
Khanna C., K. Hunter (2005) Modeling metastasis in vivo. Carcinogenesis 26, 513-523
Petrowsky, Henrik MD ; Gonen, Mithat PhD ; Jarnagin, William MD ; Lorenz, Matthias MD ; DeMatteo, Ronald MD ; Heinrich, Stefan MD ; Encke, Albrecht MD ; Blumgart, Leslie MD ; Fong, Yuman MD (2002) Second Liver Resections Are Safe and Effective Treatment for Recurrent Hepatic Metastases from Colorectal Cancer: A Bi-institutional Analysis.
Annals of Surgery 235, 863-871
Rees M, und John TG (2001) Current status of surgery in colorectal metastases to the liver, Hepatogastroenterology. Mar-Apr;48(38):341-4
Takayasu K, Y Shima, Y Muramatsu, N Moriyama, T Yamada, M Makuuchi, H Hasegawa, S Hirohashi (1987) Hepatocellular carcinoma: treatment with intraarterial iodized oil with and without chemotherapeutic agents Radiology, Vol 163, 345-351
Bruix J, Llovet JM, Castells A, Montana X, Bru C, Ayuso MC, Vilana R, Rodes J. (1998) Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution. Hepatology 27, 1578–83.
Andrew S. Kennedy M.D., F.A.C.R.O, Douglas Coldwell M.D, Charles Nutting D.O, Ravi Murthy M.D., F.A.C.P, Daniel E. Wertman, Jr M.D., Stephen P. Loehr M.D. Carroll Overton M.D, Steven Meranze M.D, Jerry Niedzwiecki M.D, and Scott Sailer M.D. (2006) Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases.
International Journal of Radiation Oncology*Biology*Physics 65 (2), 412-425
Kuvshinoff Y. Fong (2007) Surgical Therapy of Liver Metastases. Seminars in Oncology 34, 177-185
Lau W Y, Lai E C H (2007) Hepatic resection for colorectal liver metastases. Singapore Med J; 48, 635–639
Gudjonsson B (1987) Cancer of the pancreas. 50 years of surgery. Cancer 60, 2284.
Parker S. L., Tong T., Bolden S., Wingo P. A., (1997) Cancer statistics. CA Cancer J Clin 47, 5-27
Urrutia P., Di Magno E. P., (1997) Pancreatic cancer: cellular and molecular mechanism. Encyclopedia of cancer II, 1201-1211
Takahashi T., Ishikura H., Motohara T., Okushiba S., Dohke M., Katoh H. (1997) Perineural invasion by ductal adenocarcinoma of the pancreas. J Surg Oncol 65, 164-70
Marczell A., Glaser K., Karner J., Mischinger H. J., Schratter-Sehn A., Tatzer G. (1998) Pancreatic and periampullary cancer, ACO-Manual (Austrian Society of Surgical Oncology) zu finden unter: www.aco.at/manual/pankreas/stat.html
Klöppel G und Heitz PU (1984) Nesidioblastosis: a clinical entity with heterogeneous lesions of the pancreas. In:
Falkmer S, Hakanson R, Sundler F (eds) Evolution and tumour pathology of the neuroendocrine system. Elsevier, Amsterdam New York Oxford, pp 349–370
Gibbs RA, Weinstock GM, Metzker ML, Muzny DM, Sodergren EJ, Scherer S, Scott G, Steffen D, Worley KC, Burch PE, Okwuonu G, Hines S, Lewis L, DeRamo C, Delgado O, Dugan-Rocha S, Miner G, Morgan M, Hawes A, Gill R, Celera , Holt RA, Adams MD, Amanatides PG, Baden-Tillson H, Barnstead M, Chin S, Evans CA, Ferriera S, Fosler C, Glodek A, Gu Z, Jennings D, Kraft CL, Nguyen T, Pfannkoch CM, Sitter C, Sutton GG, Venter JC, Woodage T, Smith D, Lee HM, Gustafson E, Cahill P, Kana A, Doucette-Stamm L, Weinstock K, Fechtel K, Weiss RB, Dunn DM, Green ED, Blakesley RW, Bouffard GG, De Jong PJ, Osoegawa K, Zhu B, Marra M,Schein J, Bosdet I, Fjell C, Jones S, Krzywinski M, Mathewson C, Siddiqui A, Wye N, McPherson J, Zhao S, Fraser CM, Shetty J, Shatsman S, Geer K, Chen Y, Abramzon S, Nierman WC, Havlak PH, Chen R, Durbin KJ, Egan A, Ren Y, Song XZ, Li B, Liu Y, Qin X, Cawley S, Worley KC, Cooney AJ, D'Souza LM, Martin K, Wu JQ, Gonzalez-Garay ML, Jackson AR, Kalafus KJ, McLeod MP, Milosavljevic A, Virk D, Volkov A, Wheeler DA, Zhang Z, Bailey JA, Eichler EE, Tuzun E, Birney E, Mongin E, Ureta-Vidal A, Woodwark C, Zdobnov E, Bork P, Suyama M, Torrents D, Alexandersson M, Trask BJ, Young JM, Huang H, Wang H, Xing H, Daniels S, Gietzen D, Schmidt J, Stevens K, Vitt U, Wingrove J, Camara F, Mar Albà M, Abril JF, Guigo R, Smit A, Dubchak I, Rubin EM, Couronne O, Poliakov A, Hübner N, Ganten D, Goesele C, Hummel O, Kreitler T, Lee YA, Monti J, Schulz H, Zimdahl H, Himmelbauer H, Lehrach H, Jacob HJ, Bromberg S, Gullings-Handley J, Jensen- Seaman MI, Kwitek AE, Lazar J, Pasko D, Tonellato PJ, Twigger S, Ponting CP, Duarte JM, Rice S, Goodstadt L, Beatson SA, Emes RD, Winter EE, Webber C, Brandt P, Nyakatura G, Adetobi M, Chiaromonte F, Elnitski L, Eswara P, Hardison RC, Hou M, Kolbe D, Makova K, Miller W, Nekrutenko A, Riemer C, Schwartz S, Taylor J, Yang S, Zhang Y, Lindpaintner K, Andrews TD, Caccamo M, Clamp M,Clarke L, Curwen V, Durbin R, Eyras E, Searle SM, Cooper GM, Batzoglou S, Brudno M, Sidow A, Stone EA, Venter JC, Payseur BA, Bourque G, López-Otín C, Puente XS, Chakrabarti K, Chatterji S, Dewey C, Pachter L, Bray N, Yap VB, Caspi A, Tesler G, Pevzner PA, Haussler D, Roskin KM, Baertsch R, Clawson H, Furey TS, Hinrichs AS, Karolchik D, Kent WJ, Rosenbloom KR, Trumbower H, Weirauch M, Cooper DN, Stenson PD, Ma B, Brent M, Arumugam M, Shteynberg D, Copley RR, Taylor MS, Riethman H, Mudunuri U, Peterson J, Guyer M, Felsenfeld A, Old S, Mockrin S, Collins F; Rat Genome Sequencing Project Consortium. (2004) Genome sequence of the Brown Norway rat yields insights into mammalian evolution Nature 428, 493-521
Cooper C. R., C. H. Chay, J. D. Gendernalik, H. L. Lee, J. Bhatia, R. S. Taichman, L. K. MCCauley, E. T. Keller, K. J. Pienta (2003) Stromal factors involved in prostate carcinoma metastasis to bone.Cancer 97, 739-747
De Wever O, Mareel M (2003) Role of tissue stroma in cancer cellinvasion. J. Pathol. 200, 429-447
Schmidt-Hansen, B., J. Klingelhofer, B. Grum-Schwensen, A. Christensen, S. Andresen, C. Kruse, T. Hansen, N. Ambartsumian, E. Lukanidin, M. Grigorian (2004): Functional significance of metastasis-inducing S100A4 (Mts1) in tumor-stroma interplay. J. Biol. Chem. 279, 24498-24504
Sikder, H., D. L. Huso, H. Zhang, B. Wang, B. Ryu, S. T. Hwang, J. D. Powell, R. M. Alani (2003): Disruption of ld1 reveals major differences in angiogenesis between transplanted and autothonous tumours. Cancer Cell 4, 291-299
Alani R. M., C. F. Silverthorn, K. Orosz. (2004) Tumor angiogenesis in mice and men. Cancer Biol. Ther. 3, 498-500
Germer CT, Isbert C, Albrecht D, Roggan A, Pelz J, Ritz JP, Müller G, Buhr HJ (1999) Laser-induced thermotherapy combined with hepatic arterial embolization in the treatment of liver tumors in a rat tumor model Ann Surg.230, 55-62
Hagenaars M, S. Zwaveling, P.J.K. Kuppen, N.G. Ensink, A.M.M. Eggermont, M.E. Hokland, P.H. Basse, C.J.H. Van de Velde, G.J. Fleuren and U. Nannmark (1998) Characteristics of Tumor Infiltration by Adoptivly Transferred and Endogenous Natural-Killer Cells in a Syngeneic Rat Model: Implications for the Mechanism Behind anti-Tumor Responses. Int. J. Cancer: 78, 783–789
Hagenaars M, Ron Koelemij, N. Geeske Ensink, Jaap D. H. van Eendenburg, Ronald L. P. van Vlierberghe, Alexander M. M. Eggermont, Cornelis J. H. van deVelde, Gert Jan Fleuren, Peter J. K. Kuppen (2000)The development of novel mouse monoclonal antibodies against the CC531 rat colonadenocarcinoma. Clin Exp Metastasis 18, 281–289
Marquet, R.L., D.L.Westbroek, and J.Jeekel (1984) Interferon treatment of a transplantable rat colon adenocarcinoma: importance of tumor site. Int.J.Cancer 33, 689-692
Thomas C, Nijenhuis AM, Timens W, et al. (1993) Liver metastasis model of colon cancer in the rat: immunohistochemical characterization. Invasion Metastasis 13, 102–112
Li X, Mikkelsen IM, Mortensen B, Winberg JO, Huseby NE (2004) Butyrate reduces liver metastasis of rat colon carcinoma cells in vivo and resistance to oxidative stress in vitro. Clin Exp Metastasis 21, 331-338
Nestler G, Schulz HU, Schubert D, Kruger S, Lippert H, Pross M (2005) Impact of taurolidine on the growth of CC531 coloncarcinoma cells in vitro and in a laparoscopic animal model in rats. Surg Endosc 19, 280-284
Oosterling SJ, van der Bij GJ, Meijer GA, Tuk CW, van Garderen E, van Rooijen N, Meijer S, van d S, Jr, Beelen, RH, van Egmond M (2005) Macrophages direct tumour histology and clinical outcome in a colon cancer model. J Pathol 207, 147-155
van Duijnhoven FH, Aalbers RI, Rovers JP, Terpstra OT, Kuppen PJ (2003) Immunological aspects of photodynamic therapy of liver tumors in a rat model for colorectal cancer. Photochem Photobiol 78, 235-240
van Duijnhoven FH, Tollenaar RA, Terpstra OT, Kuppen PJ (2005) Locoregional therapies of liver metastases in a rat CC531 coloncarcinoma model results in increased resistance to tumour rechallenge. Clin Exp Metastasis 22, 247-253
Wittmer A, Khazaie K, Berger MR (1999) Quantitative detection of lac-Z-transfected CC531 colon carcinoma cells in an
orthotopic rat liver metastasis model. Clin Exp Metastasis 17, 369-376
Saenger J., Leible M, Seelig MH, Berger MR (2004) Chemoembolisation of rat liver metastases with irinotecan and quantification of tumor cell reduction. J Cancer Res Clin Oncol 130, 203-210
Seelig MH, Leible M, Sanger J, Berger MR (2004) Chemoembolization of rat liver metastasis with microspheres and gemcitabine followed by evaluation of tumor cell load by chemiluminescence. Oncol Rep 11, 1107-1113
Rodenbach M, Eyol E, Seelig MH, Berger MR (2005) Combination treatment of CC531-lac-Z rat liver metastases by chemoembolization with pemetrexed disodium and gemcitabine. J Cancer Res Clin Oncol 131, 289-299
Mook, O. R., J. Van Marle, H. Vreeling-Sindelarova, R. Jonges, W. M. Frederiks, C. J. Van Norden (2003): Visualisation of early events in tumor formation of eGFP-transfected rat colon cancer cells in liver. Hepatology 38, 295-304
Matzku, S., Komitowski, D., Mildenberger, M.& Zoller, M. (1983). Characterization of BSp73, a spontaneous rat tumor and ist in vivo selected variants showing different metastasizing capacities. Invasion Metastasis 3, 109-123
Knierim M., Paku, S., Paweletz, N. and Spieß, E. (1986) Ultrastructural studies on the Lung colonization by nonmetastatic ret tumor cells. Anticancer. Res 6, 669-682.
Paweletz N. Paku, S., Werling, H. O. and Spiess, E. (1986) Experimental approaches to problems of invasion and metastasis. Anticancer. Res 6, 119-128
Ackerman NB. (1974) The blood supply of experimental liver metastases. IV. Changes in vascularity with increasing tumor growth. Surgery 75, 589–596
Archer SG, Gray BN. (1989) Vascularization of small liver metastases. Br J Surg 76, 545–548
Blanchard RJ, Grotenhuis I, Lafave JW, Perry JF, Jr. (1965) Blood supply to hepatic V2 carcinoma implants as measured by radioactive microspheres. Proc Soc Exp Biol Med 118, 465–468
Breedis C, Young G. (1954) The blood supply of neoplasms in the liver. Am J Pathol 30, 969–977
Aliberti C., M. Tilli, G. Benea and G. Fiorentini (2006) Trans-arterial Chemoembolization (TACE) of Liver Metastases from Colorectal Cancer Using Irinotecan-Eluting Beads: Preliminary Results. Anticancer Research 2, 3793-3796
Varela María, María Isabel Real, Marta Burrel, Alejandro Forner, Margarita Sala, Mercé Brunet, Carmen Ayuso, Lluis Castells, Xavier Montañá, Josep M. Llovet and Jordi Bruix (2007) Chemoembolization of hepatocellular carcinoma with drug eluting beads: Efficacy and doxorubicin pharmacokinetics Journal of Hepatology 46, 474-481
Teder H, und Johansson CJ. (1993) The effect of different dosages of degradable starch microspheres (Spherex) on the distribution of doxorubicin regionally administered to the rat. Anticancer Res 13, 2161-4
Taguchi T. (1995) Liver tumor targeting of drugs: Spherex, a vascular occlusive agent Gan To Kagaku Ryoho 22, 969-76.

Toplam 108 adet kaynakça vardır.

Ayrıntılar

Birincil Dil	Türkçe
Bölüm	Derleme
Yazarlar	Ergül Eyol Bu kişi benim
Yayımlanma Tarihi	27 Temmuz 2014
Yayımlandığı Sayı	Yıl 2014 Cilt: 4 Sayı: 1

Kaynak Göster

APA	Eyol, E. (2014). Sık Rastlanan Karaciğer Metastazları ve Modelleri. Çağdaş Tıp Dergisi, 4(1), 44-52.
AMA	Eyol E. Sık Rastlanan Karaciğer Metastazları ve Modelleri. J Contemp Med. Temmuz 2014;4(1):44-52.
Chicago	Eyol, Ergül. “Sık Rastlanan Karaciğer Metastazları Ve Modelleri”. Çağdaş Tıp Dergisi 4, sy. 1 (Temmuz 2014): 44-52.
EndNote	Eyol E (01 Temmuz 2014) Sık Rastlanan Karaciğer Metastazları ve Modelleri. Çağdaş Tıp Dergisi 4 1 44–52.
IEEE	E. Eyol, “Sık Rastlanan Karaciğer Metastazları ve Modelleri”, J Contemp Med, c. 4, sy. 1, ss. 44–52, 2014.
ISNAD	Eyol, Ergül. “Sık Rastlanan Karaciğer Metastazları Ve Modelleri”. Çağdaş Tıp Dergisi 4/1 (Temmuz 2014), 44-52.
JAMA	Eyol E. Sık Rastlanan Karaciğer Metastazları ve Modelleri. J Contemp Med. 2014;4:44–52.
MLA	Eyol, Ergül. “Sık Rastlanan Karaciğer Metastazları Ve Modelleri”. Çağdaş Tıp Dergisi, c. 4, sy. 1, 2014, ss. 44-52.
Vancouver	Eyol E. Sık Rastlanan Karaciğer Metastazları ve Modelleri. J Contemp Med. 2014;4(1):44-52.

Makale Dosyaları

Tam Metin